이홍규 교수
전문진료분야
폐식도외과, 폐암, 식도암, 흉선종, 기흉, 흉강경수술, 다빈치로봇수술, 하지정맥류, 다한증
전화 예약
1577-1801
기본정보
학력
2020.03 ~ 2022.02한림대학교 대학원 박사 2017.09 ~ 2019.08한림대학교 대학원 석사 2000.03 ~ 2007.02한림대학교 의과대학 학사 |
경력
2022.03 ~ 한림대학교성심병원 흉부외과 임상부교수 2017.03 ~ 2022.02한림대학교성심병원 흉부외과 임상조교수 2015.05 ~ 2017.02삼성서울병원 흉부외과 임상강사 2012.05 ~ 2015.04국립목포병원 공중보건의 2008.03 ~ 2012.02한림대학교성심병원 흉부외과 전공의 |
학회활동
2015.05 ~ 대한흉부종양외과학회 정회원 2012.02 ~ 대한흉부심장혈관외과학회 정회원 |
수상이력
2013.04보건복지부장관 표창장 |
논문
Risk for Esophageal Cancer Based on Lifestyle Factors-Smoking, Alcohol Consumption, and Body Mass Index: Insight from a South Korean Population Study in a Low-Incidence Area (journal of clinical medicine)
Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals (HEALTHCARE)
Management of patients with bilateral recurrent laryngeal nerve paralysis following esophagectomy (THORACIC CANCER)
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma (Diagnostic Pathology)
Clinical outcomes of extracorporeal membrane oxygenation in acute traumatic lung injury: A retrospective study (Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine)
Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer (Pathology Research and Practice)
Limited Clinical and Diagnostic Utility of Circulating Tumor DNA Detection in Patients with Early-Stage Well-Differentiated Thyroid Cancer: Comparison with Benign Thyroid Nodules and Healthy Individuals (HEALTHCARE)
Management of patients with bilateral recurrent laryngeal nerve paralysis following esophagectomy (THORACIC CANCER)
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma (Diagnostic Pathology)
Clinical outcomes of extracorporeal membrane oxygenation in acute traumatic lung injury: A retrospective study (Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine)
Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer (Pathology Research and Practice)